{"AllianceGenome": "10959", "HGNC": "10959", "MIM": "604843", "_id": "10599", "_version": 1, "accession": {"genomic": ["AC022335.8", "AJ400749.1", "AJ400750.1", "AJ400751.1", "AJ400752.1", "AJ400753.1", "AJ400754.1", "AJ400755.1", "AJ400756.1", "AJ400757.1", "AJ400758.1", "AJ400759.1", "AJ400760.1", "AJ400761.1", "AJ400762.1", "AY945934.1", "CH471094.1", "CP068266.2", "CQ969227.1", "CS172507.1", "GN060123.1", "JX547012.1", "JX547013.1", "JX547014.1", "NC_000012.12", "NC_060936.1", "NG_011745.1"], "protein": ["AAD38323.1", "AAF20212.1", "AAH20696.1", "AAH54878.1", "AAH70172.1", "AAI05597.1", "AAI14377.1", "AAX20114.1", "AFV58023.1", "AFV58024.1", "AFV58025.1", "BAA78639.1", "BAG35809.1", "CAB62577.1", "CAB97007.1", "CAI38410.1", "CAJ33680.1", "CAX52185.1", "EAW96420.1", "EAW96421.1", "NP_006437.3", "Q9Y6L6.2"], "rna": ["AB026257.1", "AF060500.1", "AF205071.2", "AJ132573.1", "AK312970.1", "BC005243.2", "BC020696.1", "BC054878.1", "BC070172.1", "BC105596.1", "BC114376.1", "NM_006446.5"], "translation": [{"protein": "AAH70172.1", "rna": "BC070172.1"}, {"protein": "BAG35809.1", "rna": "AK312970.1"}, {"protein": "AAI14377.1", "rna": "BC114376.1"}, {"protein": "AAH20696.1", "rna": "BC020696.1"}, {"protein": "AAI05597.1", "rna": "BC105596.1"}, {"protein": "AAF20212.1", "rna": "AF205071.2"}, {"protein": "CAB62577.1", "rna": "AJ132573.1"}, {"protein": "AAD38323.1", "rna": "AF060500.1"}, {"protein": "NP_006437.3", "rna": "NM_006446.5"}, {"protein": "BAA78639.1", "rna": "AB026257.1"}, {"protein": "AAH54878.1", "rna": "BC054878.1"}]}, "alias": ["HBLRR", "LST-1", "LST1", "OATP-C", "OATP1B1", "OATP2", "OATPC", "SLC21A6"], "ensembl": {"gene": "ENSG00000134538", "protein": "ENSP00000256958", "transcript": "ENST00000256958", "translation": [{"protein": "ENSP00000256958", "rna": "ENST00000256958"}], "type_of_gene": "protein_coding"}, "entrezgene": "10599", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 24.2437111916, "exp_mis": 189.517237395, "exp_syn": 77.8771824889, "lof_z": 0.0490304234937655, "mis_z": -2.93059306101625, "mu_lof": 1.65472424706e-06, "mu_mis": 1.65249116422e-05, "mu_syn": 6.51029095622e-06, "n_lof": 24.0, "n_mis": 272.0, "n_syn": 81.0, "p_li": 3.45238778980654e-16, "p_null": 0.990102284215368, "p_rec": 0.00989771578463161, "syn_z": -0.219377124684491}, "bp": 2076, "cds_end": 21392123, "cds_start": 21294508, "n_exons": 14, "nonpsych": {"exp_lof": 21.6582861187, "exp_mis": 171.246780336, "exp_syn": 70.20175292, "lof_z": 0.138916770754411, "mis_z": -2.72707140678059, "mu_lof": 1.65472424706e-06, "mu_mis": 1.65249116422e-05, "mu_syn": 6.51029095622e-06, "n_lof": 21.0, "n_mis": 242.0, "n_syn": 72.0, "p_li": 5.22388747733396e-14, "p_null": 0.975574280955221, "p_rec": 0.0244257190447265, "syn_z": -0.135126213350618}, "nontcga": {"exp_lof": 22.2764728528, "exp_mis": 174.328128695, "exp_syn": 71.6192685458, "lof_z": 0.266790046720389, "mis_z": -2.66669079615553, "mu_lof": 1.65472424706e-06, "mu_mis": 1.65249116422e-05, "mu_syn": 6.51029095622e-06, "n_lof": 21.0, "n_mis": 245.0, "n_syn": 75.0, "p_li": 8.79162664344415e-14, "p_null": 0.964129110201582, "p_rec": 0.03587088979833, "syn_z": -0.25294015957055}, "transcript": "ENST00000256958.2"}, "exons": [{"cdsend": 21239189, "cdsstart": 21141574, "chr": "12", "position": [[21131193, 21131236], [21141513, 21141658], [21172649, 21172791], [21174576, 21174709], [21176775, 21176897], [21178575, 21178722], [21178921, 21179020], [21196945, 21197188], [21200507, 21200672], [21202490, 21202686], [21205867, 21206033], [21217118, 21217303], [21222299, 21222364], [21224721, 21224839], [21238978, 21239796]], "strand": 1, "transcript": "NM_006446", "txend": 21239796, "txstart": 21131193}], "exons_hg19": [{"cdsend": 21392123, "cdsstart": 21294508, "chr": "12", "position": [[21284127, 21284170], [21294447, 21294592], [21325583, 21325725], [21327510, 21327643], [21329709, 21329831], [21331509, 21331656], [21331855, 21331954], [21349879, 21350122], [21353441, 21353606], [21355424, 21355620], [21358801, 21358967], [21370052, 21370237], [21375233, 21375298], [21377655, 21377773], [21391912, 21392730]], "strand": 1, "transcript": "NM_006446", "txend": 21392730, "txstart": 21284127}], "generif": [{"pubmed": 11477075, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 11483603, "text": "The promoter of SLC21A6 gene was characterized and regulated by HNF 1alpha."}, {"pubmed": 12130747, "text": "Genetic polymorphisms: allele frequencies in the Japanese population and functional analysis"}, {"pubmed": 12130747, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12196548, "text": "A naturally occurring mutation in the gene causes impaired membrane localization of the hepatocyte uptake transporter"}, {"pubmed": 12490595, "text": "human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation"}, {"pubmed": 12670950, "text": "a role for OATP2 in hepatocyte bilirubin transport is unlikely"}, {"pubmed": 12811365, "text": "Clinical trial of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 12811365, "text": "commonly occurring single-nucleotide polymorphisms in OATP-C, such as T521C (Val174Ala), are likely to be associated with altered pharmacokinetics of pravastatin"}, {"pubmed": 15116054, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15226675, "text": "In heterozygous carriers the pharmacokinetics of pravastatin were higher compared to non-carriers."}, {"pubmed": 15226675, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15319464, "text": "neonates who carry the 211 and 388 variants in the UGT1A1 and OATP 2 genes, respectively, as well as feed with breast milk are at high risk to develop severe hyperbilirubinemia."}, {"pubmed": 15519273, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15535988, "text": "Inhibition of OATP1B1 is an important mechanism for drug-induced unconjugated hyperbilirubinemia."}, {"pubmed": 15548849, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15864125, "text": "UGT1A1, OATP2 and G6PD genes have roles in genetic predisposition to unconjugated hyperbilirubinemia"}, {"pubmed": 15864131, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15952872, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15961978, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16004557, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 16198652, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16198653, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16255851, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 16513443, "text": "Increased exposures of OATP1B1 substrates might be expected in individuals who have the poor transporter phenotype or are treated with an OATP1B1 inhibitor"}, {"pubmed": 16513443, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16515396, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 16515396, "text": "single nucleotide polymorphisms has been proposed to cause functional alternations in OATP1B1 with shown consequences for the pharmacokinetics of drugs that are OATP1B1 substrates"}, {"pubmed": 16534140, "text": "OATP1B1 play an important roles in CDCA uptake into the liver."}, {"pubmed": 16542205, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16568260, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16568260, "text": "SLCO1B1 haplotypes seem to play a role in basal cholesterol homeostasis."}, {"pubmed": 16678544, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16678545, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16722833, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16758257, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16758257, "text": "Sequence variations of SLCO1B1 occur at high frequencies in the Caucasian population."}, {"pubmed": 16784736, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16796707, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16847425, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16847425, "text": "SLCO1B1 polymorphism does not affect the extent of induction of hepatic CYP3A4 by rifampicin."}, {"pubmed": 16906022, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16917677, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17047488, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17108811, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17108811, "text": "SLCO1B1 polymorphism markedly affects the pharmacokinetics of active simvastatin acid, but has no significant effect on parent simvastatin."}, {"pubmed": 17412826, "text": "results indicate that OATP1B3/OATP-8 and OATP1B1/OATP-C most likely function as bidirectional facilitated diffusion transporters and that GSH is not a substrate or activator of their transport activity."}, {"pubmed": 17415554, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17415554, "text": "We found eight polymorphic variants that differed in genotypic and allelic frequencies between the Chinese, Malay and Indian populations."}, {"pubmed": 17439540, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17439540, "text": "The 521T-->C polymorphism of SLCO1B1 appears to modulate significantly the total cholesterol-lowering efficacy of pravastatin in Chinese patients with CHD."}, {"pubmed": 17460607, "text": "Although the SLCO1B1 polymorphism was found to have a significant effect on the pharmacokinetics of pitavastatin, a nonsynonymous ABCG2 variant, 421C>A, did not appear to be associated with the altered pharmacokinetics of pitavastatin."}, {"pubmed": 17460607, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17473846, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17496208, "text": "Bosentan uptake into Chinese hamster ovary cells expressing human OATP1B1 or OATP1B3, and was efficiently inhibited by cyclosporin A, rifampicin, and to a lesser extent by sildenafil."}, {"pubmed": 17568401, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17568401, "text": "Suggest a potential association between the OATP1B1 genetic polymorphisms and altered rosuvastatin pharmacokinetics in Korean populations."}, {"pubmed": 17622941, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17635496, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17641954, "text": "cAMP-PKA regulation of OATPC membrane expression involves the Golgi complex."}, {"pubmed": 17766002, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17883959, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17885626, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17906856, "text": "Observational study of gene-disease association, gene-gene interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17923851, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17932728, "text": "HNF1alpha is an essential regulator of OATP1B1 mRNA expression and thus the level of HNF1alpha expression is one of the major determinants of interindividual variability in OATP1B1 mRNA expression."}, {"pubmed": 17973861, "text": "Genetic polymorphism in SLCO1B1 is a major determinant of interindividual variability in the serum bilirubin level."}, {"pubmed": 17973861, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17989996, "text": "Data demonstrated that the frequent SLCO1B1 SNP c.1929A>C had no effect on the hepatic OATP1B1 protein expression and on the transport properties."}, {"pubmed": 17989996, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17996736, "text": "Observational study of genotype prevalence and genetic testing. (HuGE Navigator)"}, {"pubmed": 17996736, "text": "most common allele was SLCO1B1*1b, while SLCO1B1*5 was rare or abse"}, {"pubmed": 18154446, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 18154446, "text": "selective pressure may have acted on SLCO1B1 during human dispersal favoring low-activity variants in the north"}, {"pubmed": 18159134, "text": "Indicated genetic variation in SLCO1B1 in Japanese population."}, {"pubmed": 18159134, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 18180273, "text": "A set of double transfectants expressing OATP1B3 combined with OAT1B1 can be used as a tool for rapid identification of hepatic uptake and efflux transporters of many organic anions that are substrates of OATP1B1 or OATP1B3."}, {"pubmed": 18185926, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 18185926, "text": "results demonstrate a high sequence variability of OATP1B1 within different popuations"}, {"pubmed": 18187595, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18187595, "text": "SLCO1B1 polymorphism had no significant effect on the plasma pharmacokinetics or pharmacodynamics of nateglinide or its M7 metabolite."}, {"pubmed": 18192894, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18221820, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18314419, "text": "Alterations of OATP1BB1 function by oral antidiabetic drugs have to be considered as potential mechanisms underlying drug-drug interactions."}, {"pubmed": 18321482, "text": "Pregnane X receptor ligands, by inhibiting OATP1B1-mediated uptake, can lead to drug-drug interactions at the transporter level."}, {"pubmed": 18399713, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18408565, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18408565, "text": "Substrate dependency in the consequences of the SLCO1B1*15 variant could modulate the effect of SLCO1B1 polymorphism on the disposition of pitavastatin and pravastatin."}, {"pubmed": 18443034, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18499754, "text": "OATP1B1-Ala174 displays decreased transport activity and thereby gives rise to higher bilirubin, estrone sulfate, and T4 sulfate levels in carriers of this polymorphism."}, {"pubmed": 18499754, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18518855, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18551036, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18551036, "text": "Pharmacokinetics of ezetimibe is influenced by OATP1B1 polymorphisms in healthy participants after single dose administration."}, {"pubmed": 18558634, "text": "Eight nonsynonymous OATP1B1 gene variants were detected in children with hereditary hyperbilirubinemia; degree of genetic heterogeneity and variant coexpression across OATP1B1 gene points to polygenic nature of this disease."}, {"pubmed": 18558634, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 18641915, "text": "SLCO1B1 polymorphism is associated with Pharmacokinetic interaction between pravastatin and olmesartan."}, {"pubmed": 18650507, "text": "We have identified common variants in SLCO1B1 that are strongly associated with an increased risk of statin-induced myopathy."}, {"pubmed": 18695635, "text": "SLCO1B1 polymorphism significantly influences plasma mycophenolic acid glucuronide pharmacokinetics in Japanese renal transplant recipients."}, {"pubmed": 18781850, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18781850, "text": "The common *14 allele of OATP1B1, which is distinguished by the presence of the c.463C>A polymorphism, is associated with enhanced lipid-lowering efficacy in this study."}, {"pubmed": 18794729, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18794729, "text": "low activity SLCO1B1 c.521CC genotype is associated with an increased cholesterol synthesis rat"}, {"pubmed": 18823304, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18854776, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19005461, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19122343, "text": "Genetic variations of SLCO1B1 are identified in the three major ethnic groups (Chinese, Malay, and Indian) of the Singaporean population in this first comprehensive analysis of the SLCO1B1 gene in an Asian population."}, {"pubmed": 19122343, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 19129086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19129086, "text": "Polymorphisms in the CYP2C8 drug-metabolising enzyme gene, but not the SLCO1B1 drug transporter gene, significantly influence rosiglitazone disposition in humans."}, {"pubmed": 19238116, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19238654, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19238654, "text": "The extent of gemfibrozil-repaglinide interaction depends on SLCO1B1 genotype."}, {"pubmed": 19243019, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19293444, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19293444, "text": "The SLCO1B1 gene 388A>G polymorphism does not appear to play a significant role in susceptibility to gallstone formation."}, {"pubmed": 19343046, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19349540, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19374892, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19387419, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19387419, "text": "SLCO1B1 polymorphism considerably affects the disposition of several endogenous bile acids and bile acid synthesis marker.indicating that OATP1B1 plays an important role in the hepatic uptake of bile acids in vivo in humans"}, {"pubmed": 19390945, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19397531, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19397531, "text": "Thai infants with variant in the UGT1A1 at nt 211 or with G-6-PD deficiency are at higher risk for developing neonatal hyperbilirubinemia."}, {"pubmed": 19414484, "text": "Genetic variation of UGT1A1 and SLCO1B1 is associated with the total serum bilirubin levels."}, {"pubmed": 19414484, "text": "Meta-analysis and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19442037, "text": "In this review, organic anion transporting polypeptide (OATP)1B1 is an uptake transporter specifically expressed in the liver, and is considered important for drugs, particularly as its pharmacological target organ is the liver."}, {"pubmed": 19590950, "text": "We analysed 48,000 gene transcripts in 132 invasive breast carcinomas to identify two novel genes (OATP2 and FABP7) significantly associated with the basal-like or basal phenotype class of breast cancers"}, {"pubmed": 19620935, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19642078, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19667110, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19760661, "text": "Functional studies of chimeras showed that transmembrane domain 10 is critical for the function of OATP1B1."}, {"pubmed": 19771428, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19776292, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19833260, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19833260, "text": "SLCO1B1*5 genotype and female sex were associated mild statin-induced myalgia side effects."}, {"pubmed": 19842932, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19858149, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19858149, "text": "coexpression of the G6PD African A- mutation with UGT1A1 and/or SLCO1B1 variants was seen more frequently in neonatal hyperbilirubinemia"}, {"pubmed": 19890249, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19901119, "text": "Germline genetic variation in SLCO1B1 is associated with methotrexate pharmacokinetics and clinical effects."}, {"pubmed": 19901119, "text": "Observational study and genome-wide association study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19934028, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19952871, "text": "SLCO1B1 is a very important pharmacogene."}, {"pubmed": 19956635, "text": "Uncategorized study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20031551, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20040338, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20051929, "text": "Antiretroviral protease inhibitors, but not non-nucleoside reverse transcriptase inhibitors, are substrates for OATP1A2, OATP1B1 and OATP1B3."}, {"pubmed": 20078617, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20173083, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 20175818, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20207952, "text": "Clinical trial of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20212519, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20347093, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20389299, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20403997, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20406215, "text": "SLCO1B1 polymorphism unlikely affects the response to these antidiabetics."}, {"pubmed": 20514852, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20514852, "text": "Variants of OATP2 gene were not significant risk factors associated with severe hyperbilirubinemia in Malaysian Chinese infants."}, {"pubmed": 20602615, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20635135, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20635135, "text": "data suggest that among the many known transporters common variations of PXR, SLCO1A2, SLCO1B1, SLCO1B3, and SLCO2B1 do not contribute to breast carcinogenesis"}, {"pubmed": 20660695, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20660695, "text": "Polymorphisms in the SLCO1B1 gene associated with lower rifampin exposure were more frequent among black subjects."}, {"pubmed": 20679960, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20712525, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20827719, "text": "OATP1B1 and nuclear receptors may play an important and heretofore unrecognized role during cholestasis nd drug-induced liver injury."}, {"pubmed": 20837016, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20839930, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20877131, "text": "Forty nine nucleotide sequence variants leading to ten major haplotypes in the SLCO1B1 gene were identified in caucasian Canadians."}, {"pubmed": 20877131, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 20973885, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21072184, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 21072184, "text": "Results indicated both flavopiridol and flavopiridol-glucuronide are substrates of the SLCO1B1/OATP1B1 transporter."}, {"pubmed": 21092521, "text": "OATP1B1 A388G polymorphism has a notable influence on the serum bilirubin level in neonatal hyperbilirubinemia patients."}, {"pubmed": 21243006, "text": "Findings provide further support for a role for SLCO1B1 genotype in simvastatin-associated myopathy, and suggest that this association may be stronger for simvastatin compared with atorvastatin."}, {"pubmed": 21245207, "text": "OATP1B1, current knowledge: expression, function, substrate characteristics, pharmacogenetics, and role in drug interactions [REVIEW]"}, {"pubmed": 21309757, "text": "findings show one SNP (i.e., rs4149014) showed correlation with essential hypertension (EH) in the Uyghur population; the minor allele of SNP rs4149014 at the SLCO1B1 promoter showed association with increased risk for EH"}, {"pubmed": 21327909, "text": "SLCO1B1*1B/*1B genotype is associated with reduced pharmacokinetic exposure after a single dose oral administration of 2 mg repaglinide, including decreased AUC(0-infinity) and increased clearance of repaglinide."}, {"pubmed": 21457551, "text": "study found evidence that genetic variation in SLCO1B1 is associated with breast cancer risk in postmenopausal women, particularly among those using estrogen-progestin therapy"}, {"pubmed": 21500146, "text": "Male sex and two polymorphic forms of the OATP-2 gene (388/411-411 and 388-411) increased the risk of neonatal nonphysiological hyperbilirubinemia."}, {"pubmed": 21655991, "text": "Genetic polymorphism in SLCO1B1 does not affect pharmacokinetics of UDCA, suggesting that OATP1B1 is not rate-limiting to the hepatic uptake of therapeutic UDCA."}, {"pubmed": 21691816, "text": "we studied a series of hepatocellular carcinomas from livers that underwent liver transplantation and correlated the expression of OATP 1B1/1B3 with morphological features"}, {"pubmed": 21709081, "text": "SLCO1B1 rs4149032 was present in most patients and was associated with substantially reduced rifampin exposure"}, {"pubmed": 21719246, "text": "Data suggest OATP1B1 and OATP1B3 are high-affinity paclitaxel transporters expressed in ovarian cancer cell lines and tumor tissues (or when expressed as recombinant proteins in Xenopus laevis oocytes)."}, {"pubmed": 21743379, "text": "There was no statistically significant association between LPV or RTV AUC or CL, and CYP3A5, ABCB1, or SLCO1B1 A388G polymorphisms."}, {"pubmed": 21787759, "text": "This study demonstrated that plated primary human hepatocytes are useful as an in vitro model for OATP1B1/1B3-mediated uptake studies, but the culture time may substantially change the uptake kinetics."}, {"pubmed": 21849517, "text": "Digoxin inhibited the uptake of probe substrates of OATP1B1 (IC(50) of 47 muM), OATP1B3 (IC(50) > 8.1 muM), and OATP2B1 (IC(50) > 300 muM), but not OATP1A2 in transfected cell lines."}, {"pubmed": 21851379, "text": "The rs4149056 SNP did not significantly affect the pharmacodynamics of pravastatin."}, {"pubmed": 21882531, "text": "Subjects with the 521T --> C mutation in OATP1B1 absorbed less rosuvastatin than subjects without the mutation."}, {"pubmed": 21902813, "text": "gender, but not SLCO1B1 or CYP7A1 polymorphism, has a major effect on the fasting plasma concentrations of individual bile acids"}, {"pubmed": 21992719, "text": "SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group."}, {"pubmed": 22016628, "text": "Data indicate that organic anion transporter SLCO1B1 c.388A>G polymorphism causes significant increase in atorvastatin response and may be a marker for predicting efficacy of lipid-lowering therapy."}, {"pubmed": 22041697, "text": "is expressed on the basolateral membrane of hepatocytes and can facilitate hepatic uptake of certain clinically relevant drugs.(review)"}, {"pubmed": 22088425, "text": "The SLCO1B1 *1b haplotype was significantly associated with peptic ulcer."}, {"pubmed": 22136368, "text": "genotype and haplotype distributions are highly variable among populations of the same self-reported colour and geographical region"}, {"pubmed": 22147369, "text": "Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition."}, {"pubmed": 22178260, "text": "We found that the frequencies of polymorphisms and haplotypes of ABCB1, SLCO1B1 and ABCC2 were similar in patients with ATD-induced hepatitis and ATD-tolerant controls."}, {"pubmed": 22189199, "text": "Presence of the rs4149056 non-synonymous SNP at the SLCO1B1 gene locus can significantly decrease the pravastatin induced LDL cholesterol lowering response in the elderly."}, {"pubmed": 22203093, "text": "OATP1B1 mRNA was detected in intrahepatic cholestasis of pregnancy placentas and control placentas, but protein expression of OATP1B1 was not found in any of the placentas."}, {"pubmed": 22232210, "text": "Data show that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3."}, {"pubmed": 22240838, "text": "Cyclosporine A has a long-lasting inhibitory effect on OATP1B1 and OATP1B3."}, {"pubmed": 22505549, "text": "SLCO1B1 c.388A>G polymorphism could play a role in the inter-individual variation of clinical response to simvastatin in Brazilians"}, {"pubmed": 22562052, "text": "the OATP1B1 *15 haplotype is an important predisposing factor for rifampin-induced liver injury."}, {"pubmed": 22574206, "text": "amino acids essential for estrone-3-sulfate transport function of OATP1B1"}, {"pubmed": 22695893, "text": "there was no remarkable difference in any pharmacokinetic parameters of olmesartan between subjects with and without any major haplotypes in the three transporter genes we tested- SLCO1B1, SLCO1B3 and ABCC2"}, {"pubmed": 22749334, "text": "Polymorphisms in SLCO1B1 were not associated with serum bilirubin levels in Chinese patients. Statins increased bilirubin levels and this effect was independent of the polymorphisms."}, {"pubmed": 22771883, "text": "Genetic polymorphisms of OATP1B1 are signal confounders in gadoxetic acid-enhanced liver MR imaging. No pharmacokinetic characteristics of gadoxetic acid were influenced by genetic polymorphisms of OATP1B1 and OATP1B3."}, {"pubmed": 22842957, "text": "Both SLCO1B1 521 T>C and the CYP2C9*3 polymorphisms can significantly affect the pharmacokinetics of nateglinide."}, {"pubmed": 23010650, "text": "review discusses the potential influence of extrahepatic OATP1B expression on homeostasis and pathophysiology and its implications for pharmacotherapy in general [review]"}, {"pubmed": 23190519, "text": "in end-stage renal failure patients, some uremic toxins are related to the downregulation of intestinal MRP2 and hepatic OATP1B1 and/or OATP2B1."}, {"pubmed": 23216274, "text": "study aims to investigate the relationship between colorectal cancer and the functional common variants of SLCO1B1 (OATP1B1) and to estimate the prevalence of these variants in the Turkish population"}, {"pubmed": 23233662, "text": "Data show that methotrexate clearance was associated with polymorphisms in the organic anion transporter gene SLCO1B1 SNP rs4149056."}, {"pubmed": 23243220, "text": "Human OATP1A/1B transporters play an important role in plasma and tissue distribution of the structurally diverse chemotherapeutics methotrexate ( and paclitaxel"}, {"pubmed": 23248200, "text": "Several oral antidiabetic drugs affect the OATP1B1-mediated uptake of rosuvastatin in vitro."}, {"pubmed": 23263738, "text": "SLCO1B1 polymorphisms were not associated with the lipid-lowering effects of atorvastatin and simvastatin in Chinese hyperlipidemics."}, {"pubmed": 23285087, "text": "Asparagine residues that are possibly involved in N-glycosylation were substituted with glutamine residues and identified three glycosylation sites (Asn134, Asn503 and Asn516) within the structure of OATP1B1."}, {"pubmed": 23340295, "text": "These findings signify a unique role for OATP1B1 and OATP1B3 in the elimination of sorafenib-glucuronide and suggest a role for these transporters in the in vivo handling of glucuronic acid conjugates of drugs."}, {"pubmed": 23361102, "text": "OATP1B1 phenotype is more important than CYP3A4 and MDR1 phenotypes for the individual pharmacokinetic variability of atorvastatin."}, {"pubmed": 23436703, "text": "This review discusses gene-drug interactions, including a proposed dynamic effect on statin therapy by genetic variants in SLCO1B1 and CYP3A4 in liver cells, the main target site where statins block cholesterol synthesis. [review]"}, {"pubmed": 23461378, "text": "a role of OATP1B1 in the hepatic uptake of xenobiotics into human hepatocytes"}, {"pubmed": 23471819, "text": "Report PCR method for direct/rapid genotyping of SLCO1B1 388A>G and 521T>C in human blood specimens."}, {"pubmed": 23503447, "text": "SLCO1B1 521T-C tends to be associated with higher lopinavir concentrations in AIDS patients with targeted polymorphisms."}, {"pubmed": 23556337, "text": "Compared to non-SLCO1B1*17 carriers, SLCO1B1*17 carriers had higher peak plasma concentration and AUC of the acid and lactone forms of pivastatin"}, {"pubmed": 23625433, "text": "There was no significant difference in pharmacokinetic parameters or hypoglycemic effects of repaglinide among SLCO1B1 genotypes in either the pitavastatin or control group."}, {"pubmed": 23652803, "text": "SLCO1B1 rs4149056 variant is associated with stomatitis in childhood acute lymphoblastic leukemia."}, {"pubmed": 23670789, "text": "Treatment with SD rifampin, which inhibits the OATP1B1/3 transporter system, did not substantially influence the SD pharmacokinetics of anacetrapib."}, {"pubmed": 23708174, "text": "There appears to be no increased risk of myalgia among users of rosuvastatin who carry the rs4363657C or the rs4149056C allele in SLCO1B1."}, {"pubmed": 23778707, "text": "polymorphisms for which there is a compelling body of literature supporting their clinical relevance: OATP1B1 (c.521T>C, p.V174A, rs4149056) .... The clinical evidence demonstrating their role in variation in pharmacokinetics and pharmacodynamics"}, {"pubmed": 23850112, "text": "This study demonstrated that the 388 G>A mutation of the SLCO1B1 gene is a risk factor for developing neonatal hyperbilirubinemia in Chinese neonates, but not in white, Thai, Brazilian, or Malaysian populations"}, {"pubmed": 23858103, "text": "Trp258 and Trp259 play different roles in the uptake of different substrates by OATP1B1."}, {"pubmed": 23886114, "text": "In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia."}, {"pubmed": 23929842, "text": "B cell deficiency attenuates Oatp1a4 mRNA expression in immune-mediated liver disease."}, {"pubmed": 23930675, "text": "Polymorphisms in CYP2C9, CYP2C19 and SLC10A1 had minimal lipid-lowering effects."}, {"pubmed": 23942138, "text": "data replicate the association of SLCO1B1 variants with statin-induced myopathy."}, {"pubmed": 23970802, "text": "Common variants in SLCO1B1 were associated with differences in arsenic metabolites in a preliminary candidate gene study."}, {"pubmed": 24090270, "text": "SLCO1B1 polymorphic variant is asscociated with neonatal hyperbilirubinemia in Chinese neonates."}, {"pubmed": 24194513, "text": "Knockin of OATP1B1 or OATP1B3 partially restored control clearance."}, {"pubmed": 24263182, "text": "In the Rotterdam Study, results show an association between c.521T>C polymorphism of SLCO1B1 and dose decrease or switching, as indicators of adverse drug reactions, and provided risk factors for this association."}, {"pubmed": 24420746, "text": "Male sex and SLCO1B1c.463CA genotype increase the risk of lower rifampin plasma exposure."}, {"pubmed": 24595600, "text": "Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2."}, {"pubmed": 24623479, "text": "This study investigates the effect of OATP1B1 genotype as a covariate on repaglinide pharmacokinetics and drug-drug interaction risk using a reduced physiologically-based pharmacokinetic model."}, {"pubmed": 24673529, "text": "results strongly suggest that SLOL1B1 is part of the estrone-3-sulfate binding site/translocation pathway but is not directly involved in binding/translocation of estradiol-17beta-glucuronide"}, {"pubmed": 24740327, "text": "Data indicate that HEK-293T cells expressing liver specific organic anion transporter peptides OATP1B1 and OATP1B3 undergo apoptosis upon nodularin treatment."}, {"pubmed": 24762081, "text": "Our results, for the first time, indicated that polymorphisms of SLCO1B1 rs2306283 might be associated with bladder cancer risk."}, {"pubmed": 24810685, "text": "The review shows that among all the loci identified, only the *5 allele of SLCO1B1 was strongly and consistently associated with the onset of myopathy."}, {"pubmed": 24825069, "text": "human OATP1B1, OATP1B3 and OATP1A2 can transport docetaxel in vivo."}, {"pubmed": 24855184, "text": "The expression of OATP1B1 and -1B3 in the humanized models did not significantly alter liver or plasma concentrations of rosuvastatin."}, {"pubmed": 24865931, "text": "study demonstrates that UGT1A1 and OATP2 polymorphisms were associated with altered bilirubin metabolism and could be genetic risk factors for neonatal hyperbilirubinemia"}, {"pubmed": 24989890, "text": "A pronounced OATP1B1 and comparatively low OATP1B3 protein expression in the investigated hepatocyte lot."}, {"pubmed": 25084202, "text": "There was no association between the plasma LDL-C levels and the expression and activity of ABCB1 and OATP1B1"}, {"pubmed": 25098908, "text": "Results shown that SLCO1B1 polymorphisms influence methotrexate disposition and survival in methotrexate-treated osteosarcoma patients and therefore might serve as pharmacogenetic markers of treatment outcome."}, {"pubmed": 25124723, "text": "SLCO1B1 genotype may help to identify patients with increased risk of methotrexate-related toxicity."}, {"pubmed": 25130190, "text": "SLCO1B1 c.521T > C variant decreases the clearance of methotrexate in childhood acute lymphoblastic leukemia."}, {"pubmed": 25279974, "text": "SLCO1B1 gene variants could affect the pharmacodynamics of rocuronium."}, {"pubmed": 25379722, "text": "Genetic variants of OATP1B1 leading to impaired hepatic uptake of statins translated into reduced drug efficacy in a population-based cohort."}, {"pubmed": 25391605, "text": "UGT1A1, SLCO1B1 and SLCO1B3 polymorphisms become risk factors in neonates showing 10% or greater body weight loss during the neonatal period. Inadequate feeding may increase the bilirubin burden and cause apparent hyperbilirubinemia in neonates."}, {"pubmed": 25414411, "text": "Data suggest that competitive inhibition of biological transport via OATP1B1 may account for drug-drug interactions; specificity of OATP1B1 in transport of various drugs may be key factor leading to drug-drug interactions."}, {"pubmed": 25488931, "text": "Data (including data from cloned cells expressing various levels of recombinant proteins) verify that level of expression of OATP1B1 or BCRP in plasma membrane correlates with transport of drugs (transport of estradiol glucuronide by OATP1B1)."}, {"pubmed": 25498879, "text": "Results show that patients carrying at least one SLCO1b1 haplotype have increased risk of ATDH"}, {"pubmed": 25499601, "text": "Genetic variation in SLCO1b1 may be associated with change in mammographic density after women stop using estrogen-progestin therapy."}, {"pubmed": 25578040, "text": "Data suggest that expression of SLCO1B1 and SLCO1B3 in hepatocytes can be regulated by dietary factors; expression of SLCO1B1 is up-regulated by anthocyanins/anthocyanin glycosides; expression of SLCO1B3 is down-regulated by these fruit pigments."}, {"pubmed": 25701109, "text": "The aim of this study was to evaluate the association of CYP2D6*10, OATP1B1 A388G, and OATP1B1 T521C polymorphisms with overall survival for breast cancer patients after adjuvant tamoxifen therapy."}, {"pubmed": 25812934, "text": "The mutations of OATP1B1 388GG and 521CC inhibited the activity of OATP1B1 protein, restrained the turnover capacity of OATP1B1 and reduced the entrance of tamoxifen into MCF-7 cells, resulting in weakened efficacy in the treatment of breast cancer."}, {"pubmed": 25916517, "text": "Functional SLCO1B1 variants are not associated with death/myocardial infarction in patients commonly treated with statins."}, {"pubmed": 25932441, "text": "No significant difference was observed in the lipid-lowering efficacy of statins between the wild and variant genotypes of SLCO1B1."}, {"pubmed": 25935875, "text": "Results show ticagrelor pharmacokinetics to be influenced by SNPs in SLCO1B1 though no detectable effects on efficacy or safety were found"}, {"pubmed": 25939871, "text": "Polymorphism of SLCO1B1 c.521 T > C could be a strong predictor of 6-MP dose reduction in maintenance chemotherapy in childhood ALL."}, {"pubmed": 25992810, "text": "In Czech dyslipidemia patients treated with low simvastatin or atorvastatin doses, there is no association between SLCO1B1 rs4363657 polymorphism and risk of myalgia/myopathy."}, {"pubmed": 26009271, "text": "Taken together, our present study demonstrated that PKC regulates the function of OATP1B1 by affecting internalization and recycling of the transporter protein."}, {"pubmed": 26122863, "text": "Misoprostol acid was transported across a blood-brain barrier model by MRP4 and SLCO1B1"}, {"pubmed": 26146841, "text": "SLCO1B1 and SLCO1B3 polymorphisms contributed to an increased risk of neonatal hyperbilirubinemia."}, {"pubmed": 26146896, "text": "Genetic link with cholelithiasis among pediatric SCA Tunisian patients: Examples of UGT1A1, SLCO1A2 and SLCO1B1."}, {"pubmed": 26191226, "text": "Down-regulation of OATP1B1/3 proteins may contribute to pathogenesis of jaundice accompanying advanced cholestatic liver diseases."}, {"pubmed": 26334272, "text": "the polymorphism rs2306283 at the SLCO1B1 gene determines greater HDL-C concentrations in response to atorvastatin medication in Chilean hypercholesterolemic subjects."}, {"pubmed": 26334733, "text": "these results suggest that the pharmacogenetical pattern of SLCO1B1 gene shows population specificity; therefore the examination of clinically relevant polymorphisms is important in different populations."}, {"pubmed": 26373210, "text": "this extensive analysis of the effect of SLCO1B1 polymorphisms on the pharmacokinetic profile of atorvastatin showed that SNPs may affect the inter-individual response to atorvastatin"}, {"pubmed": 26376374, "text": "T521C polymorphism associated with an increased risk of statin-related myopathy, especially in individuals receiving simvastatin [review]"}, {"pubmed": 26380303, "text": "Patients with better muscle function had the highest concentration of CK, IL-1, and TNF-a compared with less muscle function"}, {"pubmed": 26383540, "text": "transport of CPR I mediated by OATP1B1 and OATP1B3 and the transport of CPR III mediated by OATPs 1B1, 1B3 and 2B1 is time-dependent, can be saturated and inhibited"}, {"pubmed": 26409184, "text": "Results identified interethnic differences of genetic variations of the SLCO1B1, SLCO1B3, and SLCO2B1 genes in Korean population compared with other ethnic groups."}, {"pubmed": 26474710, "text": "OATP1B1- and OATP1B3-humanized mice can be used as in vivo tools to assess and possibly predict clinically relevant DDIs."}, {"pubmed": 26482301, "text": "The SLCO1B1 rs1104581 polymorphism, weight, and gender appear to play important roles for rifabutin efficiency in African HIV-Infected patients with tuberculosis."}, {"pubmed": 26562723, "text": "TM11 of OATP1B1 may face the substrate interaction pocket."}, {"pubmed": 26607661, "text": "SLCO1B1 variants are strongly associated with an increased risk of enalapril-induced cough."}, {"pubmed": 26663398, "text": "these findings demonstrate an important role for OATP1B1 in the systemic pharmacokinetics of multiple drugs used in the treatment of acute myeloid leukemia"}, {"pubmed": 26826613, "text": "Patients under pravastatin treatment prior to inguinal hernia repair presented with lower postoperative IL-10 levels with respect to the baseline concentration, regardless of the presence or absence of SLCO1B1 *1 or SLCO1B1 *5 polymorphisms."}, {"pubmed": 26960716, "text": "results suggested that Gly71Arg and Asn130Asp mutations in UGT1A1 and OATP2 genes might be involved in the development of hyperbilirubinemia in neonates."}, {"pubmed": 27098745, "text": "OATP1B1 showed high interindividual variability in relative protein expression but no statistically significant difference among the studied age groups."}, {"pubmed": 27234217, "text": "SLCO1B1*5 allele variants and patient age predict the likelihood of young women with breast cancer developing chemotherapy-induced amenorrhea."}, {"pubmed": 27449599, "text": "Organic anion-transporting polypeptides exert strong impact on disposition and toxicity of antitumor drugs. (Review)"}, {"pubmed": 27455553, "text": "The HEK-293 cell lines stably expressing human OATP1B1-wild and variant (HEK-OATP1B1, *1b and *15) are potential models to study drug transport in vitro"}, {"pubmed": 27510251, "text": "plasma rifampicin concentrations did not differ significantly between the various genotypes of the rs4149032 polymorphism of the SLCO1B1 gene in a South Indian population"}, {"pubmed": 27533851, "text": "Polymorphisms in SLCO1B1 and UGT1A1 are associated with several different sorafenib side effects"}, {"pubmed": 27594653, "text": "Critical amino acid residues in the predicted transmembrane pore influencing transport kinetics of the hepatic drug transporter OATP1B1 have been identified."}, {"pubmed": 27595674, "text": "SLCO1B1 genotype was not associated with the risk of statin-associated muscle symptoms."}, {"pubmed": 27897269, "text": "Neither the ABCB1 C3435T nor the SLCO1B1 T521C polymorphism affected edoxaban PK."}, {"pubmed": 27936281, "text": "This review describes what is currently known regarding SLCO1B1 genotype, OATP1B1 protein expression and interindividual and interethnic consequences to drug disposition, with particular focus on statin pharmacokinetics and implications for drug response and toxicity--{REVIEW}"}, {"pubmed": 27943244, "text": "Genetic polymorphisms of the UGT1A1 promoter, specifically the T-3279G phenobarbital-responsive enhancer module and (TA)7 dinucleotide repeat, as well as the intron and coding region variants of the OATP2, HMOX1, and BLVRA genes, were significantly higher among the cases than the controls."}, {"pubmed": 27977017, "text": "Although we have found quite a large number of genetic variants of the UGT1A1 and SLCO1B1 genes in the African-American population, it does not appear that they have a significant impact on the incidence of hyperbilirubinemia among this group of infants."}, {"pubmed": 28013215, "text": "Data suggest that OATP1B1, OATP1B3, and OATP2B1 participate in transport of perfluoroalkyl acids in hepatocytes; environmental pollutants transported include PFBS (perfluorobutane sulfonate), PFHxS (perfluorohexane sulfonate), and PFOS (perfluorooctane sulfonate)."}, {"pubmed": 28049954, "text": "SLCO1B1 rs113681054, SLCO1B1*5 (rs4149056), CYP3A4*1G (rs2242480), and CYP3A4*5 (rs776746) polymorphisms had no effect on the PK/PD of ticagrelor in healthy Chinese volunteers"}, {"pubmed": 28063966, "text": "Our results did not indicate a strong association between OATP1B1 or OATP1B3 inhibition and hyperbilirubinemia"}, {"pubmed": 28157071, "text": "SLCO1B1 polymorphisms appear to be associated with the development of adverse drug reactions to regorafenib."}, {"pubmed": 28252633, "text": "Polymorphisms of the SLCO1B1 gene ate used for predicting risk of adverse events when using statins."}, {"pubmed": 28371445, "text": "sorafenib-beta-D-glucuronide transport by OATP1B1 or murine Oatp1b2 was effectively inhibited by rifampin."}, {"pubmed": 28385543, "text": "SLCO1B1 and ABCG2 polymorphisms are better predictors of rosuvastatin exposure than ethnicity alone and could be considered in precision medicine dosing of rosuvastatin."}, {"pubmed": 28482130, "text": "Associations between SLCO1B1 521C and cholesterol response were not detected in African Americans (n = 333). Associations between CYP3A4*22 or CYP3A5*3 and cholesterol response were not detected in whites or African Americans."}, {"pubmed": 28532671, "text": "OATP1A2, OATP1B1, and OATP2B1 can mediate cellular uptake of ochratoxin A, which could aggravate OTA toxicity."}, {"pubmed": 28627631, "text": "OATP1B1 genetic polymorphism is associated with decreased uptake of tamoxifen and its metabolite, endoxifen."}, {"pubmed": 28653144, "text": "Allele frequencies of two transporters (OATP1B1 and BCRP) are key contributors to ethnic variability in transporter substrate pharmacokinetics."}, {"pubmed": 28812116, "text": "This nested case-control study showed that rs4149056 (SLCO1B1, 521T > C) was associated with rosuvastatin-induced myotoxicity in Chinese patients, and that 521C mutant allele increased the risk of rosuvastatin-associated myotoxicity."}, {"pubmed": 28940218, "text": "rs4149056 in SLCO1B1 was associated with statin-related myotoxicity."}, {"pubmed": 28975866, "text": "SLCO1A2 and SLCO1B1 gene treatment over time interactions were associated with gametocytemia clearance rate."}, {"pubmed": 29023140, "text": "We compared the carrier frequency of Cytochrome P450 Enzymes and Transport Proteins markers among the Russian population living in Moscow with Dagestan ethnic groups. Statistically significant differences for the following gene polymorphisms: CYP2C19*17, CYP2C9*3, ABCB1 (C3435T), SLCO1B1*5 were found between the Russian population and the three ethnic groups of the Dagestan republic."}, {"pubmed": 29095107, "text": "SLCO1B1 rs4149056 genetic variants can affect the HD-MTX-related toxicity in Chinese patients with NHL."}, {"pubmed": 29263072, "text": "Effect of genetic variation of NAT2 on isoniazid and SLCO1B1 and CES2 on rifampin pharmacokinetics in Ghanaian children with tuberculosis has been reported."}, {"pubmed": 29285751, "text": "Endogenous metabolite-mediated communication between OAT1/OAT3 and OATP1B1 may explain the association between SLCO1B1 SNPs and methotrexate toxicity."}, {"pubmed": 29337310, "text": "the murine solute carrier organic anion-transporting polypeptide B2 (OATP1B2) is a mediator of paclitaxel-induced neurotoxicity"}, {"pubmed": 29422623, "text": "The authors show that human OATP1B1, 1B3 and 2B1 proteins transport a series of commercially available viability dyes that are generally believed to be impermeable to intact cells."}, {"pubmed": 29463526, "text": "The moxifloxacin area under the concentration time curve from 0 to 24 h and Cmax were significantly increased by the drug milligram-per-kilogram dosage and the genotype of variant g.-11187G>A in the SLCO1B1 gene but not by geographic region."}, {"pubmed": 29469964, "text": "The impact of the SLCO1B1 c.521 genotype was more pronounced in children, although considerable interindividual variability in SVA exposure was observed within genotype groups."}, {"pubmed": 29534995, "text": "There is lower prevalence of statin-induced myopathy-linked C allele of rs4149056 in SLCO1B1 gene in Emirati population, compared to Caucasians and Africans."}, {"pubmed": 29575099, "text": "SLCO1B1 c.388A>G, c.521T>C and g.89595T>C polymorphisms may not be useful as genetic markers of lipid-lowering response to simvastatin therapy."}, {"pubmed": 29683944, "text": "SLCO1B1 rs4149056 and rs11045879 polymorphisms may be important genetic markers to individualize 6-MP/MTX doses."}, {"pubmed": 29683977, "text": "Advanced pancreatic cancer patients with advanced pancreatic cancer with the solute carrier organic anion transporter family member 1B1 (SLCO1B1) rs4149086 AG or GG genotype may obtain good clinical results when treated with S-1-containing regimens."}, {"pubmed": 29738412, "text": "there was a significant association between the SLCO1B1 rs4149056 TT genotype and lower sulfated estrogens compared with women who were heterozygous or homozygous for the reduced function allele. Among women assigned to menopausal hormone therapy, women with the CT genotype showed a significantly greater decrease in night sweats than those with the TT genotype."}, {"pubmed": 29760129, "text": "Linear logistic regression showed that genetic variants in organic-anion-transporter-1B1- and pregnane-X-receptor-encoding genes affected third-trimester atazanavir exposure. In this prospective study, genetic variants partially explained the observed interpatient variability in third-trimester exposure to antiretrovirals."}, {"pubmed": 29944058, "text": "The four active components of Radix Ophiopogonis affect the transporting activitives of OATP1B1 and OATP1B3 in a substrate-dependent manner."}, {"pubmed": 30010042, "text": "Study determined that SLCO1B1 rs4149056 T/C genotype and C allele may be associated with exudative age-related macular degeneration, as well as with elevated serum SLCO1B1 levels. Also, higher serum SLCO1B1 levels were found to be associated with early and exudative age-related macular degeneration."}, {"pubmed": 30100615, "text": "By the polymorphisms SLCO1B1 c.521T>C and ABCG2 c.421C>A, but appear driven by a different set of variants."}, {"pubmed": 30181619, "text": "The study explored the association between polymorphisms and acitretin efficacy in psoriasis vulgaris patients. The polymorphisms rs4149056 in the SLCO1B1 gene and rs2282143 in the SLC22A1 gene were associated with efficacy, both in the discovery (P = 0.013 and P = 0.002) and validation phases (P = 0.028 and P = 0.014), based on a 50% reduction from before to after treatment of the psoriasis area severity index (PASI50)."}, {"pubmed": 30218633, "text": "OATPB1/B3 and MRP3 immunohistochemistry and signal intensity on hepatobiliary phase Gd-EOB-DTPA-enhanced MRI can help to stratify hepatocellular adenoma according to their risk of malignant transformation."}, {"pubmed": 30250148, "text": "Meta-analysis: SLCO1B1 T521C was associated with a significantly higher risk of statin-induced myopathy, especially for simvastatin, rosuvastatin, and cerivastatin."}, {"pubmed": 30336686, "text": "conclusion suggests that the interaction between the SLCO1B1 388A>G and 521T>C polymorphisms could be an important genetic determinant of hepatic function and the therapeutic efficiency of simvastatin in Chinese patients with hyperlipidemia."}, {"pubmed": 30360603, "text": "The combined effect of ABCC2 and SLCO1B1 polymorphisms tended to be associated with treatment responses in irinotecan-based treated mCRC patients."}, {"pubmed": 30368586, "text": "was reported to reduce the ability of drug transport via OATP1B1"}, {"pubmed": 30514181, "text": "The transport from plasma into hepatocytes is mediated by the SLCO1B1 protein (i.e. OATP-C). The presence of genetic polymorphisms in any of these transporting proteins has been suggested to have an additive or synergistic effect with UGT1A1 polymorphisms."}, {"pubmed": 30520341, "text": "Contrary to previous publications, CYP2C8*3 may confer increased paclitaxel metabolic activity. SLCO1B1 and CYP2C8 genotype may explain some paclitaxel pharmacokinetic variability."}, {"pubmed": 30549267, "text": "The SLCO1B1 c.521 gene variant contributes to variability in systemic exposure to pravastatin in a pediatric cohort with hypercholesterolemia."}, {"pubmed": 30569848, "text": "SLCO1B1 c.521T>C polymorphism is a valuable biomarker for the evaluation of atorvastatin safety and efficacy"}, {"pubmed": 30636082, "text": "Associations between G6PD, OATP1B1 and BLVRA variants and susceptibility to neonatal hyperbilirubinaemia in a Chinese Han population."}, {"pubmed": 30714173, "text": "Carried one copy of SLCO1B1."}, {"pubmed": 30734632, "text": "SLCO1B1 (rs4149056) was found to be the only SNP associated with tegafur-uracil (UFT) treatment-related elevation of aspartate aminotransferase (odds ratio: C/C vs T/T = 7.8, C/T vs T/T = 5.7; p = 0.037) and alanine transaminase (odds ratio: C/C vs T/T = 12.2, C/T vs T/T = 4.1; p = 0.034) levels in hepatic dysfunction in breast cancer."}, {"pubmed": 30862625, "text": "MVC disposition involves intestinal P-gp/CYP3A and hepatic OATP1B1/CYP3A interplay."}, {"pubmed": 30982223, "text": "OATP1B1 genotype can modulate the effects of Ccyclosporin A on biomarker levels; the extent of modulation differs among the biomarkers."}, {"pubmed": 30989645, "text": "CYP2C9 AND SLCO1B1 have enantiospecific effects on fluvastatin pharmacokinetics"}, {"pubmed": 31022310, "text": "SLCO1B1 variant rs2306283, UGT1A1*28 TA promoter repeat, and BCRP variant rs2231142 had no effect on letermovir PK."}, {"pubmed": 31047942, "text": "Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions."}, {"pubmed": 31093828, "text": "Increased phosphorylation, but not impaired membrane localization, in association with the reduced transport function of the V174A-OATP1B1 single-nucleotide polymorphism."}, {"pubmed": 31124411, "text": "Higher concentrations of atazanavir(ATV) and ritonavir were significantly associated with CYP3A5 6986 GG and SLCO1B1 521 TC or CC. Female patients had significantly higher ATV plasma concentration than male patients."}, {"pubmed": 31190621, "text": "These findings suggest SLCO1B1 polymorphisms may have an effect on estrogenic response to AI treatment, and therefore may adversely impact the anticancer effectiveness of these agents."}, {"pubmed": 31220337, "text": "SLCO1B1 c.521C>T SNP is a replicable genetic risk factor for statin myopathy."}, {"pubmed": 31240859, "text": "Results suggested that genetic polymorphisms of SLCO1B1 were associated with susceptibility to MMI-DILI. The genetic polymorphism of SLCO1B1 may be important predisposing factors for MMI-induced hepatotoxicity."}, {"pubmed": 31253110, "text": "SLCO1B1 c.388A > G variant incidence and the severity of hyperbilirubinemia in Indonesian neonates."}, {"pubmed": 31254566, "text": "The amino-terminal region, which includes TM1 and the amino-terminus of OATP1B1, is important for proper function of the membrane protein."}, {"pubmed": 31298164, "text": "SLCO1B1 and ABCB1 genetic variants are associated with statin-induced myopathy"}, {"pubmed": 31299240, "text": "OATP1B1- and 1B3-transfected cells could selectively uptake UDCA acyl glucuronide, but not UDCA, OCA, and OCA acyl glucuronide. In summary, the liver disposition of OCA is different from that of UDCA due to hepatic uptake."}, {"pubmed": 31342800, "text": "SLCO1B1 rs4363657 polymorphism was a significant risk factor for statin-associated muscle adverse events"}, {"pubmed": 31375612, "text": "Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis."}, {"pubmed": 31408569, "text": "microRNA-206 modulates the hepatic expression of the organic anion-transporting polypeptide 1B1."}, {"pubmed": 31446145, "text": "Proposal of a Parameter for OATP1B1 Inhibition Screening at the Early Drug Discovery Stage."}, {"pubmed": 31727004, "text": "presence of the SLCO1B1*1b/*1b diplotype may be a risk factor for aspirin-induced gastric mucosal erosion in elderly Chinese men taking aspirin and an ACE inhibitor or ARB concomitantly"}, {"pubmed": 31746415, "text": "Organic anion transporting polypeptide 1A2 mediates fentanyl uptake in cultured cells."}, {"pubmed": 31789383, "text": "Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB-rifampicin sensitivity among Ugandan patients."}, {"pubmed": 31857620, "text": "Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects."}, {"pubmed": 31888882, "text": "Influence of Uridine Diphosphate Glucuronosyltransferase Family 1 Member A1 and Solute Carrier Organic Anion Transporter Family 1 Member B1 Polymorphisms and Efavirenz on Bilirubin Disposition in Healthy Volunteers."}, {"pubmed": 31917523, "text": "Alternative Splicing of the SLCO1B1 Gene: An Exploratory Analysis of Isoform Diversity in Pediatric Liver."}, {"pubmed": 31957862, "text": "Assessment of pharmacogenomic SLCO1B1 assay for prediction of neuromuscular pain in type 2 diabetes mellitus and cardiovascular patients: preliminary results."}, {"pubmed": 32024416, "text": "MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis."}, {"pubmed": 32100958, "text": "Genetic Diversity in Drug Transporters: Impact in African Populations."}, {"pubmed": 32453264, "text": "Association of SLCO1B1 c.521T>C (rs4149056) with discontinuation of atorvastatin due to statin-associated muscle symptoms."}, {"pubmed": 32460379, "text": "Intestinal P-gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications."}, {"pubmed": 32577754, "text": "Genetic Factors and Delayed TSB Monitoring and Treatment as Risk Factors Associated with Severe Hyperbilirubinemia in Term Neonates Admitted for Phototherapy."}, {"pubmed": 32587096, "text": "Organic Anion Transporting Polypeptide-Mediated Hepatic Uptake of Glucuronide Metabolites of Androgens."}, {"pubmed": 32594851, "text": "Association between SLCO1B1 polymorphism distribution frequency and blood lipid level in Chinese adults."}, {"pubmed": 32690641, "text": "Rifampicin Transport by OATP1B1 Variants."}, {"pubmed": 32891149, "text": "The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population."}, {"pubmed": 32961019, "text": "Substantially Increased Plasma Coproporphyrin-I Concentrations Associated With OATP1B1*15 Allele in Japanese General Population."}, {"pubmed": 32961594, "text": "Identification of Glycochenodeoxycholate 3-O-Glucuronide and Glycodeoxycholate 3-O-Glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers."}, {"pubmed": 33025831, "text": "SLCO1B1 variants as predictors of methotrexate-related toxicity in children with juvenile idiopathic arthritis."}, {"pubmed": 33150478, "text": "Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis."}, {"pubmed": 33386894, "text": "The influence of recipient SLCO1B1 rs2291075 polymorphism on tacrolimus dose-corrected trough concentration in the early period after liver transplantation."}, {"pubmed": 33428894, "text": "Leucine heptad motifs within transmembrane domains affect function and oligomerization of human organic anion transporting polypeptide 1B1."}, {"pubmed": 33501733, "text": "Genetic factors involved in delayed methotrexate elimination in children with acute lymphoblastic leukemia."}, {"pubmed": 33608664, "text": "A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy."}, {"pubmed": 33658230, "text": "SLCO1B1: Application and Limitations of Deep Mutational Scanning for Genomic Missense Variant Function."}, {"pubmed": 34114646, "text": "Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and Atorvastatin."}, {"pubmed": 34423691, "text": "Study on the relationship between SLCO1B1 and ApoE gene polymorphisms and the risk of coronary heart disease in the Mongolian population."}, {"pubmed": 34423897, "text": "SLCO1B1 *15 allele is associated with methotrexate-induced nausea in pediatric patients with inflammatory bowel disease."}, {"pubmed": 34558822, "text": "Protective Effects of Statin Therapy in Cirrhosis Are Limited by a Common SLCO1B1 Transporter Variant."}, {"pubmed": 34563206, "text": "Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China."}, {"pubmed": 34580865, "text": "Performance of Plasma Coproporphyrin I and III as OATP1B1 Biomarkers in Humans."}, {"pubmed": 34647232, "text": "The Effect of Single Nucleotide Variations in the Transmembrane Domain of OATP1B1 on in vitro Functionality."}, {"pubmed": 34668025, "text": "Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study."}, {"pubmed": 34674552, "text": "Prevalence of protective haplotypes of the SLCO1B1 gene for statin transport in Mexican populations."}, {"pubmed": 34721737, "text": "OATP1B1 Plays an Important Role in the Transport and Treatment Efficacy of Sorafenib in Hepatocellular Carcinoma."}, {"pubmed": 34726639, "text": "Association between SLCO1B1 polymorphism and methotrexate-induced hepatotoxicity: a systematic review and meta-analysis."}, {"pubmed": 34749751, "text": "Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia."}, {"pubmed": 35034348, "text": "SLCO1B1*5 Allele Is Associated With Atorvastatin Discontinuation and Adverse Muscle Symptoms in the Context of Routine Care."}, {"pubmed": 35501760, "text": "Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population."}, {"pubmed": 35968761, "text": "SLCO1B1 and ABCB1 variants synergistically influence the atorvastatin treatment response in South Indian coronary artery disease patients."}, {"pubmed": 36169244, "text": "SLCO1B1 c.521T>C gene polymorphism decreases hypoglycemia risk in sulfonylurea-treated type 2 diabetic patients."}, {"pubmed": 36193736, "text": "Effects of SLCO1B1 on elimination and toxicities of high-dose methotrexate in pediatric acute lymphoblastic leukemia."}, {"pubmed": 36314075, "text": "Association between single nucleotide polymorphism SLCO1B1 gene and simvastatin pleiotropic effects measured through flow-mediated dilation endothelial function parameters."}, {"pubmed": 36377985, "text": "Analysis of APOE and SLCO1B1 Gene Polymorphism and Correlation with Dyslipidemia in China."}, {"pubmed": 36382878, "text": "ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population."}, {"pubmed": 36478296, "text": "Effects of the SLCO1B1 A388G single nucleotide polymorphism on the development, clinical parameters, treatment, and survival of multiple myeloma cases in a Polish population."}, {"pubmed": 36624704, "text": "Polymorphisms of SLCO1B1 Gene in Sundanese Ethnic Population of Tuberculosis Patients in Indonesia."}, {"pubmed": 36779498, "text": "Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder."}, {"pubmed": 36964102, "text": "SLCO1B1 and SLCO1B3 genetic mutations in Taiwanese patients with Rotor syndrome."}, {"pubmed": 37101315, "text": "Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor-containing regimen."}, {"pubmed": 37221222, "text": "SLCO1B1*5 is protective against non-senile cataracts in cohort prescribed statins: analysis in a British-South Asian cohort."}, {"pubmed": 37222158, "text": "The frequency of major ABCG2, SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing."}, {"pubmed": 37355503, "text": "SLCO1B1 Polymorphisms are Associated with the Susceptibility to Pulmonary Tuberculosis in Chinese Females."}, {"pubmed": 37442606, "text": "Interaction of Human OATP1B1 with PDZK1 Is Required for Its Trafficking to the Hepatocyte Plasma Membrane."}, {"pubmed": 37674011, "text": "Cryo-EM structures of human organic anion transporting polypeptide OATP1B1."}, {"pubmed": 37723174, "text": "Structure of human drug transporters OATP1B1 and OATP1B3."}, {"pubmed": 37749323, "text": "Association between SLCO1B1 genetic polymorphisms and bleeding risk in patients treated with edoxaban."}, {"pubmed": 38019119, "text": "SLCO1B1 variants and the risk of antituberculosis drug-induced hepatotoxicity: a systematic review and meta-analysis."}, {"pubmed": 38279097, "text": "Associations between UGT1A1, SLCO1B1, SLCO1B3, BLVRA and HMOX1 polymorphisms and susceptibility to neonatal severe hyperbilirubinemia in Chinese Han population."}, {"pubmed": 38405139, "text": "The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia."}, {"pubmed": 38515340, "text": "Non-targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function."}], "genomic_pos": {"chr": "12", "end": 21239796, "ensemblgene": "ENSG00000134538", "start": 21131194, "strand": 1}, "genomic_pos_hg19": {"chr": "12", "end": 21392180, "start": 21284136, "strand": 1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0006805", "qualifier": "involved_in", "term": "xenobiotic metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006811", "qualifier": "involved_in", "term": "monoatomic ion transport"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0015711", "pubmed": 10358072, "qualifier": "involved_in", "term": "organic anion transport"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0015721", "qualifier": "involved_in", "term": "bile acid and bile salt transport"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0015721", "qualifier": "involved_in", "term": "bile acid and bile salt transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0015732", "qualifier": "involved_in", "term": "prostaglandin transport"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0042167", "qualifier": "involved_in", "term": "heme catabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0043252", "qualifier": "involved_in", "term": "sodium-independent organic anion transport"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0043252", "qualifier": "involved_in", "term": "sodium-independent organic anion transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0055085", "qualifier": "involved_in", "term": "transmembrane transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0070327", "qualifier": "involved_in", "term": "thyroid hormone transport"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0009925", "pubmed": 35307651, "qualifier": "located_in", "term": "basal plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0016020", "pubmed": 10358072, "qualifier": "located_in", "term": "membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0016323", "qualifier": "is_active_in", "term": "basolateral plasma membrane"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0008514", "pubmed": [10873595, 19129463, 26383540], "qualifier": "enables", "term": "organic anion transmembrane transporter activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0015125", "qualifier": "enables", "term": "bile acid transmembrane transporter activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0015125", "qualifier": "enables", "term": "bile acid transmembrane transporter activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0015132", "pubmed": 10873595, "qualifier": "enables", "term": "prostaglandin transmembrane transporter activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0015347", "qualifier": "enables", "term": "sodium-independent organic anion transmembrane transporter activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0015347", "qualifier": "enables", "term": "sodium-independent organic anion transmembrane transporter activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0015349", "qualifier": "enables", "term": "thyroid hormone transmembrane transporter activity"}]}, "homologene": {"genes": [[8364, 613085], [9031, 418187], [9544, 705308], [9598, 465331], [9606, 10599]], "id": 74575}, "interpro": [{"desc": "Kazal domain", "id": "IPR002350", "short_desc": "Kazal_dom"}, {"desc": "Organic anion transporter polypeptide", "id": "IPR004156", "short_desc": "OATP"}, {"desc": "Major facilitator superfamily domain", "id": "IPR020846", "short_desc": "MFS_dom"}, {"desc": "Kazal domain superfamily", "id": "IPR036058", "short_desc": "Kazal_dom_sf"}, {"desc": "MFS transporter superfamily", "id": "IPR036259", "short_desc": "MFS_trans_sf"}], "ipi": "IPI00295376", "map_location": "12p12.1", "name": "solute carrier organic anion transporter family member 1B1", "other_names": ["OATP-2", "liver-specific organic anion transporter 1", "organic anion transporter SLC21A6", "sodium-independent organic anion-transporting polypeptide 2", "solute carrier family 21 (organic anion transporter), member 6", "solute carrier organic anion transporter family member 1B1"], "pantherdb": {"HGNC": "10959", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1351899", "ortholog_type": "O", "panther_family": "PTHR11388", "taxid": 10090, "uniprot_kb": "Q9JJL3"}, {"RGD": "69300", "ortholog_type": "O", "panther_family": "PTHR11388", "taxid": 10116, "uniprot_kb": "Q9QZX8"}, {"Ensembl": "ENSGALG00000019277", "ortholog_type": "O", "panther_family": "PTHR11388", "taxid": 9031, "uniprot_kb": "A0A3Q3A502"}, {"ZFIN": "ZDB-GENE-030131-5044", "ortholog_type": "O", "panther_family": "PTHR11388", "taxid": 7955, "uniprot_kb": "A0A0R4IW35"}, {"ZFIN": "ZDB-GENE-100818-2", "ortholog_type": "O", "panther_family": "PTHR11388", "taxid": 7955, "uniprot_kb": "A0A0R4ICL4"}, {"WormBase": "WBGene00009023", "ortholog_type": "O", "panther_family": "PTHR11388", "taxid": 6239, "uniprot_kb": "Q93550"}, {"FlyBase": "FBgn0032123", "ortholog_type": "O", "panther_family": "PTHR11388", "taxid": 7227, "uniprot_kb": "Q9VLB3"}], "uniprot_kb": "Q9Y6L6"}, "pathway": {"kegg": {"id": "hsa04976", "name": "Bile secretion - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-159418", "name": "Recycling of bile acids and salts"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-189445", "name": "Metabolism of porphyrins"}, {"id": "R-HSA-189483", "name": "Heme degradation"}, {"id": "R-HSA-194068", "name": "Bile acid and bile salt metabolism"}, {"id": "R-HSA-382551", "name": "Transport of small molecules"}, {"id": "R-HSA-425397", "name": "Transport of vitamins, nucleosides, and related molecules"}, {"id": "R-HSA-425407", "name": "SLC-mediated transmembrane transport"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-5619102", "name": "SLC transporter disorders"}, {"id": "R-HSA-5619110", "name": "Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)"}, {"id": "R-HSA-5619115", "name": "Disorders of transmembrane transporters"}, {"id": "R-HSA-879518", "name": "Transport of organic anions"}, {"id": "R-HSA-8957322", "name": "Metabolism of steroids"}, {"id": "R-HSA-9748784", "name": "Drug ADME"}, {"id": "R-HSA-9754706", "name": "Atorvastatin ADME"}], "smpdb": [{"id": "SMP00433", "name": "Irinotecan Action Pathway"}, {"id": "SMP00600", "name": "Irinotecan Metabolism Pathway"}, {"id": "SMP00652", "name": "Mycophenolic Acid Metabolism Pathway"}, {"id": "SMP00653", "name": "Rosiglitazone Metabolism Pathway"}], "wikipathways": [{"id": "WP1604", "name": "Codeine and Morphine Metabolism"}, {"id": "WP2289", "name": "Drug Induction of Bile Acid Pathway"}, {"id": "WP229", "name": "Irinotecan pathway"}, {"id": "WP2876", "name": "Pregnane X receptor pathway"}, {"id": "WP2882", "name": "Nuclear Receptors Meta-Pathway"}, {"id": "WP5066", "name": "FOXA2 pathway"}]}, "pdb": ["8HNB", "8HNC", "8HND", "8HNH", "8K6L", "8PHW"], "pfam": ["PF03137", "PF07648"], "pharmgkb": "PA134865839", "pharos": {"target_id": 602, "tdl": "Tchem"}, "prosite": ["PS50850", "PS51465"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF261691", "relationship": "is"}, {"id": "GNF261692", "relationship": "is"}, {"id": "GNF261693", "relationship": "is"}, {"id": "GNF261694", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF039226", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF276140", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF106355", "relationship": "is"}, {"id": "GNF146001", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000012.12", "NC_060936.1", "NG_011745.1"], "protein": "NP_006437.3", "rna": "NM_006446.5", "translation": {"protein": "NP_006437.3", "rna": "NM_006446.5"}}, "reporter": {"HG-U133_Plus_2": "210366_at", "HG-U95Av2": "35570_at", "HTA-2_0": ["TC12002283.hg.1", "TC12003240.hg.1"], "HuEx-1_0": "3407683", "HuGene-1_1": "7954356", "HuGene-2_1": "16749077"}, "summary": "This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].", "symbol": "SLCO1B1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1420131"}, "unigene": "Hs.449738", "uniprot": {"Swiss-Prot": "Q9Y6L6", "TrEMBL": "Q05CV5"}, "wikipedia": {"url_stub": "SLCO1B1"}}